Position in LUCD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$773,821
+$503,840 QoQ
Shares Held
723,200
+208.0% QoQ
Ownership
0.356%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#17
of 114 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in LUCD Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026AQR CAPITAL MANAGEMENT LLC holds $3,191,787,188 across 80 Medical Devices names. LUCD ranks #66 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
9,681,750 | $413,217,085 | |
| 2 | ABT |
Abbott Laboratories
|
4,193,058 | $380,478,079 | |
| 3 | PODD |
Insulet Corp
|
2,455,135 | $373,794,300 | |
| 4 | STE |
STERIS plc
|
1,377,297 | $290,017,425 | |
| 5 | MDT |
Medtronic plc
|
3,299,627 | $258,129,817 | |
| 6 | DXCM |
Dexcom Inc
|
3,237,720 | $218,060,438 | |
| 7 | LIVN |
LivaNova PLC
|
2,356,191 | $193,749,582 | |
| 8 | HAE |
Haemonetics Corp
|
2,266,489 | $169,986,675 |
All Filings in LUCD
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $773,821 | 723,200 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $269,981 | 234,769 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $88,900 | 81,561 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $81,501 | 80,696 | Shares | Other | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||